Navigation Links
'Charismatic' organisms still dominating genomics research
Date:4/30/2014

Decades after the genomics revolution, half of known eukaryote lineages still remain unstudied at the genomic level--with the field displaying a research bias against 'less popular', but potentially genetically rich, single-cell organisms.

This lack of microbial representation leaves a world of untapped genetic potential undiscovered, according to an exhaustive survey conducted by UBC researchers of on-going genomics projects. The survey results are published in the May issue of Trends in Ecology and Evolution.

"We're still mostly analyzing the same well-known eukaryotic groups: animals, fungi and plants, in large part because their utility is more obvious, they are closer to us as humans, and frankly because we can see them with the naked eye," says Javier del Campo, lead author on the paper and an expert on the microbial ecology of protists, complex single-celled organisms.

"But from a biological diversity and a genomic point of view this anthropocentric approach is irrelevant, and potentially holds us back. We're missing the opportunity to study most of the planet's eukaryotic diversity, which means we're missing the opportunity to study a host of alternative life strategies, novel metabolic pathways, new gene functions."

The authors call for a broader, objective and species relationship-based initiative to sequence microbial eukaryotic genomes so that the breadth of their diversity is covered.

Background

The researchers analyzed all the genome research projects in operation--or projected to launch--and found that 51% of known eukaryotic lineages are not yet represented or studied at a genomic level.

Genomic database holdings are heavily biased against complex single cell organisms, particularly the Rhizaria, Amoebozoa and heterotrophic Stramenopiles lineages.

The study also analyzed the five largest eukaryotic culture collections, and determined that up to 25% of the described eukaryotic lineages have no representatives in culture.


'/>"/>

Contact: Javier del Campo
javier.delcampo@botany.ubc.ca
University of British Columbia
Source:Eurekalert

Related biology news :

1. A charismatic new lacewing from Malaysia discovered online by chance
2. Beneficial organisms react differently to parasite drug
3. Altruistic suicide in organisms helps relatives
4. New studies needed to predict how marine organisms may adapt to the futures acidic oceans
5. A new generation database to help ecological research on marine organisms
6. Converting natural gas to liquid transportation fuels via biological organisms
7. How tiny organisms make a big impact on clean water
8. Nice organisms finish first: Why cooperators always win in the long run
9. Neiker-Tecnalia and FARMARABA produce Omega 3 using marine plant micro-organisms
10. Microorganisms detected via breath test linked to body mass, fat accumulation
11. Not just cars, but living organisms need antifreeze to survive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... 2017 Summary This report provides all ... partnering interests and activities since 2010. ... Read the full report: ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ...
(Date:3/2/2017)... , March 2, 2017 Australian stem ... (ASX: CYP), has signed an agreement with the ... the Monash Biomedicine Discovery Institute and Department of Pharmacology ... conduct a further preclinical study to support the use ... of asthma.  Asthma is a chronic, ...
(Date:2/28/2017)... , February 28, 2017 News solutions ... ... Amsterdam from 14 to 16 March, Materna will ... and show how seamless travel is a real benefit for passengers. ... added biometrics to their passenger touch point solutions to take passengers ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)... 23, 2017 Kineta, Inc., a biotechnology ... therapies in immuno-oncology, today announced the discovery and ... compounds that activate interferon response factor 3 (IRF3) ... immune-mediated tumor regression in a murine colon carcinoma ... demonstrated complete tumor regression to initial drug treatment ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... announced the hire of Dr. Sigmund “Sig” Floyd as Vice President ? Global ... and joint development activities. , “Dr. Floyd’s career has spanned 30 years in ...
(Date:3/22/2017)... CAMBRIDGE, Mass. , March 22, 2017 ... announced that it has eclipsed the 130 million covered ... Cross Blue Shield of Texas . ... stages, the Company continues to enjoy strong payor acceptance ... of its clinical programs and genetic counseling, its industry-leading ...
Breaking Biology Technology: